Assessing clinically meaningful end points for the management of actinic keratosis with diclofenac 3% gel.
Rivers
Jason K
JK
Rivers
Jason J
JJ
Wolf
John
J
D000287:Administration, Topical; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D004008:Diclofenac / Q000627:therapeutic use*; D004311:Double-Blind Method; D006801:Humans; D007642:Keratosis / Q000188:drug therapy* / Q000473:pathology
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004008:Diclofenac